更新和不断发展的护理范式为绝经前患有子宫内膜癌的绝经前患者
Ray Abou Nakad1, Nadeem R Abu-Rustum2, Jennifer J Mueller2
1Memorial Sloan Kettering Cancer Center, Department of Surgery, Gynecology Service, New York, NY, USA.
概括
在更年期前的妇女中,子宫内膜癌正在增加,延迟怀孕. 本综述涵盖了这些年轻患者的节育治疗和管理策略.
科学领域:
- 妇科 妇科 妇科 妇科
- 在瘤学瘤学.
背景情况:
- 在绝经前妇女中,子宫内膜癌的发病率增加.
- 延迟第一次怀孕,通常超过30年,带来了独特的挑战.
- 对于希望保持生育能力的年轻患者来说,治疗决策是复杂的.
研究的目的:
- 审查前更年期子宫内膜癌患者目前的节育治疗和监测策略.
- 讨论非手术治疗的患者选择标准.
- 探索新的治疗选择和细微的临床场景.
主要方法:
- 现有文献的叙述性审查.
- 讨论广泛接受的患者选择标准.
- 分析当前的治疗和监测策略.
主要成果:
- 在节育管理中选择患者的确立标准.
- 接受的治疗和监测协议的概述.
- 探索扩展的标准和新的治疗方法.
结论:
- 节育管理是选择绝经前的子宫内膜癌患者的可行选择.
- 仔细选择患者和量身定制的治疗策略至关重要.
- 目前正在进行的研究旨在扩大非手术治疗的选择,并解决复杂的病例.
更多相关视频
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
15.8K
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
16.6K
相关概念视频
Disorders of the Female Reproductive System
4.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.7K
Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Hormonal Control of the Ovarian Cycle
7.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.3K
Hormonal Regulation of the Menstrual Cycle
2.0K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
